ranolazine has been researched along with Constipation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arndt, TL; Bennett, NM; Garberich, RF; Henry, TD; Schmidt, CW; Storey, KM; Traverse, JH; Wang, J | 1 |
| Bernard, CE; Beyder, A; Cima, RR; Dozois, EJ; Farrugia, G; Kline, CF; Kraichely, RE; Larson, DW; Mazzone, A; Mohler, PJ; Neshatian, L; Rhee, PL; Strege, PR | 1 |
2 other study(ies) available for ranolazine and Constipation
| Article | Year |
|---|---|
Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry).
Topics: Aged; Angina Pectoris; Cardiovascular Agents; Constipation; Deprescriptions; Diabetes Mellitus; Disease Progression; Dizziness; Drug Costs; Dyslipidemias; Edema; Female; Humans; Hypertension; Male; Medication Adherence; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Nausea; Ranolazine; Registries; Smoking; Treatment Failure; Treatment Outcome | 2020 |
Ranolazine inhibits voltage-gated mechanosensitive sodium channels in human colon circular smooth muscle cells.
Topics: Colon; Colon, Ascending; Constipation; HEK293 Cells; Humans; Muscle Contraction; Myocytes, Smooth Muscle; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Physical Stimulation; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Ranolazine | 2015 |